John T Cavan
CIK 1503738 · Chief Financial Officer · last filed 2021-05-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.2K
Companies
2
Total Filings
12
Lifetime Open-Market Net
$40.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HEPA | Chief Financial Officer | 14,800 | $0.08 | $1.2K | $27.3K | 6 | 2021-05-20 |
| Hepion Pharmaceuticals, Inc. (CTRV) Delisted | CFO | 167,947 | — | — | $13.0K | 6 | 2018-07-03 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-06-22 | Hepion Pharmaceuticals, Inc. (CTRV) Delisted | Buy (P) | +20,000 | $13.0K | EDGAR |
| 2016-08-29 | Hepion Pharmaceuticals, Inc. (CTRV) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.